Breaking News Instant updates and real-time market news.

AAL

American Airlines

$35.90

-0.25 (-0.69%)

, WMT

Walmart

$95.60

-1.11 (-1.15%)

10:20
02/08/19
02/08
10:20
02/08/19
10:20

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. American Airlines (AAL) initiated with a Hold at Argus. 2. Walmart (WMT) and Sprouts Farmers Market (SFM) were initiated with a Neutral at Buckingham, while Kroger (KR) was initiated with an Underperform. 3. Wrap Technologies (WRTC) initiated with a Buy at Chardan. 4. nLight (LASR) initiated with a Hold at Craig-Hallum. 5. RA Pharmaceuticals (RARX) initiated with a Buy at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

AAL

American Airlines

$35.90

-0.25 (-0.69%)

WMT

Walmart

$95.60

-1.11 (-1.15%)

KR

Kroger

$27.93

-0.26 (-0.92%)

SFM

Sprouts Farmers Market

$23.61

-0.14 (-0.59%)

WRTC

Wrap Technologies

$4.56

0.38 (9.09%)

LASR

nLight

$19.27

-0.55 (-2.78%)

RARX

RA Pharmaceuticals

$20.29

0.43 (2.17%)

  • 20

    Feb

  • 21

    Feb

  • 27

    Feb

  • 03

    Mar

  • 06

    Mar

AAL American Airlines
$35.90

-0.25 (-0.69%)

01/17/19
IMPC
01/17/19
NO CHANGE
Target $78
IMPC
Underperform
United Continental price target raised to $78 from $73 at Imperial Capital
Imperial Capital analyst Michael Derchin raised his price target for United Continental Holdings (UAL) to $78 citing the company's better than expected Q4 results. The analyst, however, keeps an Underperform rating on the shares. United's unit revenue momentum is expected to slow meaningfully and possibly inflect to negative territory by the second half of 2019, resulting in shares trading at similar valuations as American Airlines (AAL), Derchin tells investors in a research note. He points out United shares are currently trading at a 40% premium to American and a 5% premium to Delta Air Lines (DAL).
02/08/19
ARGS
02/08/19
INITIATION
ARGS
Hold
American Airlines initiated with a Hold at Argus
Argus analyst John Staszak initiated American Airlines with a Hold rating, saying the airline is expected to face rising costs and revenue headwinds in the near term. The analyst also warns about pressure on margins and earnings coming from the company's planned 3% increase in capacity. Staszak contends that while the airline trades at 6-times his expected forward earnings vs. 9-times peer average, the discount is warranted given its "above-average leverage and prospects for higher costs and modest revenue growth."
02/04/19
VERT
02/04/19
INITIATION
Target $35
VERT
Hold
American Airlines initiated with a Hold at Vertical Research
Vertical Research analyst Darryl Genovesi started American Airlines earlier with a Hold rating and $35 price target.
01/25/19
IMPC
01/25/19
NO CHANGE
Target $46
IMPC
Outperform
American Airlines price target raised to $46 from $42 at Imperial Capital
Imperial Capital analyst Michael Derchin raised his price target for American Airlines to $46 citing the company's better than expected earnings outlook for fiscal 2019. The stock at current levels presents an attractive opportunity with upside potential on earnings and unit revenues, and the valuation reflects low expectations, Derchin tells investors in a post-earnings research note. He keeps an Outperform rating on the shares.
WMT Walmart
$95.60

-1.11 (-1.15%)

02/05/19
NOMU
02/05/19
NO CHANGE
Target $35
NOMU
Buy
Nomura tells investors to 'rethink their cautiousness' on Synchrony
Nomura Instinet analyst Bill Carcache raised his price target for Synchrony Financial (SYF) to $35 from $33 and reiterates a Buy rating on the shares. Although the short case on Synchrony "died last quarter" as renewals quelled fears around additional partnership losses and the announced sale of the Walmart (WMT) portfolio eradicated skepticism over whether Capital One (COF) would be a buyer, many investors are reluctant to get more bullish amid a perceived lack of incremental demand for Synchrony late cycle, Carcache tells investors in a research note titled ""Time to Get in Front of SYF as It Prepares to Take Down ~20% of Its Float; Raising TP to $35." While understanding the concerns, the analyst says it is "time for those on the sidelines to rethink their cautiousness." With over $4B to spend and a "laser focus" on mitigating the loss of Walmart, the analyst views Synchrony as a "deep pocketed incremental buyer that intends to reduce its float by ~20%."
02/07/19
BUCK
02/07/19
INITIATION
BUCK
Neutral
Walmart reinstated with a Neutral at Buckingham
02/07/19
BUCK
02/07/19
INITIATION
Target $109
BUCK
Neutral
Walmart initiated with a Neutral at Buckingham
Buckingham analyst Bob Summers started Walmart with a Neutral rating and $109 price target. The analyst views Walmart as one of the best positioned companies in all of retail but believes "current and future successes" are well reflected in current valuation levels. He "would be compelled" to revisit his rating on a significant share pullback.
02/07/19
CLVD
02/07/19
NO CHANGE
CLVD
Walmart has further upside to Q4, says Cleveland Research
Cleveland Research's said WalMart US comps versus consensus are supported by an improvement in January and the 2019 outlook is positive.
KR Kroger
$27.93

-0.26 (-0.92%)

12/07/18
LOOP
12/07/18
NO CHANGE
Target $30
LOOP
Hold
Kroger near-term visibility is 'solid', says Loop Capital
Loop Capital analyst Andrew Wolf kept his Hold rating and $30 price target on Kroger after its Q3 earnings beat, saying the quarter was driven by "solid cost control and gasoline profitability". The analyst also cites Kroger's comps of 1.6% topping his forecast of 1.2% and matching the growth rate of Q2, even though the company's "aggressive" 600-store remodel progress "remains below plan". Wolf adds that Kroger's valuation is unlikely to expand without acceleration in comps growth, even though he sees the company's visibility as "solid".
10/31/18
JEFF
10/31/18
NO CHANGE
Target $35
JEFF
Buy
Jefferies sees favorable risk/reward on Kroger, ups target to $35
Jefferies analyst Christopher Mandeville says that although Kroger's grocery comp progress was pushed to fiscal 2019, greater color provided at the investor day on its shift to new, higher margin data services gives him comfort in the company's long-term profitability. The analyst believes the "wide disparity" between consensus estimates and Kroger's $3.5B fiscal 2020 EBIT target creates a favorable risk/reward. He raised his price target for the shares to $35 from $33 and keeps a Buy rating on the name.
02/07/19
BUCK
02/07/19
INITIATION
Target $24
BUCK
Underperform
Kroger initiated with an Underperform at Buckingham
Buckingham analyst Bob Summers started Kroger with an Underperform rating and $24 price target. The company has established an "overly ambitious" goal for fiscal 2020 that entails significant investment, Summers tells investors in a research note. The analyst believes deflation, competitive activity, fuel profitability, and the economic cycle pose risk to the company's EBIT growth.
02/07/19
BUCK
02/07/19
INITIATION
BUCK
Underperform
Kroger initiated with an Underperform at Buckingham
SFM Sprouts Farmers Market
$23.61

-0.14 (-0.59%)

11/30/18
11/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cree (CREE) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster citing valuation. 2. Goldman Sachs (GS) downgraded to Neutral from Buy at BofA/Merrill with analyst Michael Carrier saying the uncertainty around the 1MDB investigation could limit the stock's upside potential if markets stabilize. 3. Denbury Resources (DNR) downgraded to Perform from Outperform at Oppenheimer with analyst Tim Rezvan saying he lacks confidence that Denbury will get enough votes to close the acquisition of Penn Virginia (PVAC) and sees an increased risk of "strategic limbo" should the deal fall through. 4. Sprouts Farmers Market (SFM) downgraded to Underperform from Buy at BofA/Merrill with analyst Robert Ohems following CEO Amin Maredla's plans to leave the company. Ohems believes Maredla is leaving to pursue other interests, but said the transition comes at a difficult time given expectations Q4 and 1H 2019 are already expected to be challenging. 5. Assertio Therapeutics (ASRT) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying while the amended Nucynta royalty agreement with Collegium removes an overhang on the stock, the stock's one-year upside is limited. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/19
BUCK
02/07/19
INITIATION
Target $25
BUCK
Neutral
Sprouts Farmers Market initiated with a Neutral at Buckingham
Buckingham analyst Bob Summers started Sprouts Farmers Market with a Neutral rating and $25 price target. The analyst believes near-term headwinds relating to earnings and comparable store sales growth will "preclude valuation expansion that approaches prior highs." He envisions a range-bound stock and would opportunistically react to pricing changes.
11/30/18
BOFA
11/30/18
DOWNGRADE
BOFA
Underperform
Sprouts Farmers Market downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Robert Ohems downgraded Sprouts Farmers Market to Underperform from Buy and cut its price target to $21 from $35 following CEO Amin Maredla's plans to leave the company. Ohems believes Maredla is leaving to pursue other interests, but said the transition comes at a difficult time given expectations Q4 and 1H 2019 are already expected to be challenging. The analyst expects Q4 margin headwinds from increased investments in technology, training and wages, which should persist into 1H 2019. Further, Ohems sees risk to the company's same-store-sales outlook due to produce deflation and lower comp contribution from new stores.
02/07/19
BUCK
02/07/19
INITIATION
BUCK
Neutral
Sprouts Farmers Market initiated with a Neutral at Buckingham
WRTC Wrap Technologies
$4.56

0.38 (9.09%)

02/08/19
CHDN
02/08/19
INITIATION
Target $12.5
CHDN
Buy
Wrap Technologies initiated with a Buy at Chardan
Chardan analyst James McIlree initiated Wrap Technologies with a Buy rating and $12.50 price target.
LASR nLight
$19.27

-0.55 (-2.78%)

02/08/19
CHLM
02/08/19
INITIATION
CHLM
Hold
nLight initiated with a Hold at Craig-Hallum
02/08/19
CHLM
02/08/19
INITIATION
Target $20
CHLM
Hold
nLight initiated with a Hold at Craig-Hallum
Craig-Hallum analyst Greg Palm initiated nLight (LASR) with a Hold rating and $20 price target and advises waiting for a more attractive entry point. In a research note to investors, Palm says laser systems are taking increasing share in the broader machine tool industry, fiber lasers are gaining vs. traditional laser technologies like CO2 and YAG, and believes nLight is well-positioned to take share from IPG Photonics (IPGP) and others due to second sourcing and product differentiation. That said, he believes outsized exposure to China, a general slowing in industrial end markets and recent pricing pressure will keep a lid on overall sentiment and the stock in the near term.
12/10/18
NEED
12/10/18
NO CHANGE
Target $27
NEED
Buy
nLight price target lowered to $27 from $29 at Needham
Needham analyst James Ricchiuti lowered his price target on nLight to $27 after meeting with its management last week, reflecting the reduction of enterprise value to revenue multiple to 4.4-times from 4.7-times. The analyst also kept his Buy rating on the shares, saying the discussions indicated that the company's Q4 performance looks to be on track while the launch of its new products in 2019 is expected to support its growth at a mid-teen rate next year. Ricchiuti adds that he came away from the meetings more confident in nLight's ability to meet consensus expectations in Q4 and believes that the stock offers an "attractive risk-reward opportunity".
01/29/19
NRCS
01/29/19
NO CHANGE
NRCS
Neutral
Laser industry survey by Northcoast sees continued 2019 headwinds
Northcoast analyst Tom Hayes is keeping his Neutral rating on Laser names IPG Photonics (IPGP), Coherent (COHR), and nLIGHT (LASR) as part of his research note on the sector highlighting the findings of his December Laser Industry survey. The analyst states that although the respondents are more optimistic, they continue to see international market activity as choppy with limited visibility. Hayes further cites the respondents' concerns over "geopolitical issues, tough comps and pricing", with the second half of 2018 and early look at 2019 indicating continued headwinds but at a "slightly more muted tone".
RARX RA Pharmaceuticals
$20.29

0.43 (2.17%)

12/10/18
JEFF
12/10/18
NO CHANGE
Target $40
JEFF
Buy
RA Pharmaceuticals price target raised to $40 from $22 at Jefferies
Jefferies boosts its price target for RA Pharmaceuticals to a Street-high $40 following this morning's positive top-line results from the company's Phase 2 clinical trial evaluating zilucoplan for the treatment of generalized myasthenia gravis.
12/10/18
RBCM
12/10/18
NO CHANGE
RBCM
Outperform
RA Pharmaceuticals could be strategic target for Alexion, says RBC Capital
RBC Capital analyst Kennen MacKay believes RA Pharmaceuticals' (RARX) zilucoplan gMG data "should impress even the skeptics," but he has received questions about why the stock hasn't inflected higher on data that left him "overall highly impressed." He believes the recent run-up of the stock into the data suggests anticipation of a positive result and also thinks the upside has likely been limited by some anticipation for a dilutive financing. Commenting on why the news "isn't more negative" for Alexion (ALXN), MacKay added that he anticipates that Alexion could have strategic interest in an acquisition of RA, with sufficient financial flexibility to pursue a deal, as the latter gets closer to commercialization. MacKay maintains an Outperform rating on RA Pharmaceuticals shares.
02/08/19
STFL
02/08/19
INITIATION
Target $55
STFL
Buy
RA Pharmaceuticals initiated with a Buy at Stifel
Stifel analyst Stephen Willey started RA Pharmaceuticals with a Buy rating and $55 price target. The positive Phase 2 proof-of-concept zilucoplan data generated in generalized myasthenia gravis and paroxysmal nocturnal hemoglobinuria "cement the validity of the zilucoplan value proposition and significantly de-risk" future Phase 3 development plans, Willey tells investors in a research note. He believes RA shares at current levels remain "significantly underappreciated by investors."
12/11/18
RHCO
12/11/18
NO CHANGE
Target $35
RHCO
Buy
RA Pharmaceuticals price target raised to $35 from $28 at SunTrust
SunTrust analyst Edward Nash raised his price target on RA Pharmaceuticals to $35 and kept his Buy rating after its positive top-line results from a Phase II zilucoplan trial that are "comparable, if not better, to Soliris' Phase III REGAIN data." The analyst notes that the patients in the trial "did not require rescue therapy" and that the drug's safety profile was "mild". Nash believes that "zilucoplan is well positioned to treat broader generalized myasthenia gravis, or gMG, patients than Soliris, given its subQ delivery and a more accessible pricing."

TODAY'S FREE FLY STORIES

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

18:12
07/19/19
07/19
18:12
07/19/19
18:12
Hot Stocks
Biohaven receives CRL from FDA for application seeking NURTEC approval »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

CE

Celanese

$107.01

0.9 (0.85%)

18:01
07/19/19
07/19
18:01
07/19/19
18:01
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

F

Ford

$10.20

-0.06 (-0.58%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Periodicals
Ford plans to lay off 185 employees at Ontario plant, Reuters reports »

A union local said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 23

    Oct

RTN

Raytheon

$178.55

2.45 (1.39%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Hot Stocks
Raytheon awarded $191.01M Air Force contract modification »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UTX

United Technologies

$132.37

1.08 (0.82%)

17:44
07/19/19
07/19
17:44
07/19/19
17:44
Hot Stocks
United Technologies awarded $253.71M Air Force contract »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LMT

Lockheed Martin

$356.90

0.675 (0.19%)

17:40
07/19/19
07/19
17:40
07/19/19
17:40
Hot Stocks
Lockheed Martin awarded $1.47B Missile Defense Agency contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ARES

Ares Management

$28.13

-0.305 (-1.07%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Syndicate
Breaking Syndicate news story on Ares Management »

Ares Management files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

HAFC

Hanmi Financial

$21.68

-0.105 (-0.48%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Hot Stocks
Hanmi Financial to delay release of Q2 results »

Hanmi Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PAYS

Paysign

$17.49

-0.48 (-2.67%)

17:32
07/19/19
07/19
17:32
07/19/19
17:32
Syndicate
Breaking Syndicate news story on Paysign »

Paysign files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$43.19

0.83 (1.96%)

17:28
07/19/19
07/19
17:28
07/19/19
17:28
Hot Stocks
Methanex reaches final investment decision on methanol plant in Geismar, LA »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

17:17
07/19/19
07/19
17:17
07/19/19
17:17
Conference/Events
Credit Suisse biotech analysts to hold an analyst/industry conference call »

Biotech Analysts provide…

17:14
07/19/19
07/19
17:14
07/19/19
17:14
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

SHIP

Seanergy Marine

$0.64

-0.0425 (-6.25%)

17:05
07/19/19
07/19
17:05
07/19/19
17:05
Hot Stocks
Seanergy Maritime receives noncompliance notice from Nasdaq »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONM

Sonim

$13.42

0.24 (1.82%)

16:41
07/19/19
07/19
16:41
07/19/19
16:41
Conference/Events
Sonim management to meet with Oppenheimer »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Sep

KINS

Kingstone Companies

$8.81

0.09 (1.03%)

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Hot Stocks
Kingstone names Barry Goldstein CEO »

Kingstone Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Options
Preliminary option volume of 22.6M today »

Preliminary option volume…

BA

Boeing

$377.34

16.17 (4.48%)

, MSFT

Microsoft

$136.62

0.33 (0.24%)

16:24
07/19/19
07/19
16:24
07/19/19
16:24
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks were tentatively…

BA

Boeing

$377.34

16.17 (4.48%)

MSFT

Microsoft

$136.62

0.33 (0.24%)

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

AAPL

Apple

$202.62

-3.02 (-1.47%)

WMT

Walmart

$113.91

-0.77 (-0.67%)

DIS

Disney

$139.86

-1.76 (-1.24%)

GCI

Gannett

$9.43

1.53 (19.37%)

CRWD

Crowdstrike

$83.50

10.75 (14.78%)

SKX

Skechers

$39.00

4.25 (12.23%)

PACB

Pacific Biosciences

$5.34

-0.53 (-9.03%)

ILMN

Illumina

$293.10

-5.44 (-1.82%)

CHWY

Chewy

$30.70

-2.09 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 15

    Aug

  • 03

    Sep

  • 25

    Sep

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
07/19/19
07/19
16:20
07/19/19
16:20
Options
Closing CBOE SPX and VIX Index summary for July 19th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
07/19/19
07/19
16:17
07/19/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCBP

BCB Bancorp

$12.71

-0.09 (-0.70%)

16:17
07/19/19
07/19
16:17
07/19/19
16:17
Earnings
BCB Bancorp reports Q2 EPS 30c, consensus 30c »

Net interest margin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
07/19/19
07/19
16:16
07/19/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNXM

CNX Midstream Partners

$14.30

-0.205 (-1.41%)

16:16
07/19/19
07/19
16:16
07/19/19
16:16
Hot Stocks
CNX Midstream Partners raises quarterly distribution 3.6% to 38.65c per unit »

CNX Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

TELL

Tellurian

$7.25

0.22 (3.13%)

16:16
07/19/19
07/19
16:16
07/19/19
16:16
Syndicate
Breaking Syndicate news story on Tellurian »

Tellurian files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:15
07/19/19
07/19
16:15
07/19/19
16:15
General news
Breaking General news story  »

Boston Federal Reserve…

ROKU

Roku

$106.83

-2.18 (-2.00%)

16:13
07/19/19
07/19
16:13
07/19/19
16:13
Conference/Events
Roku management to meet with Oppenheimer »

Bull/Bear Luncheon to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 07

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.